Vetter to implement packaging serialisation to reduce drug counterfeiting

Germany-based pharmaceutical packaging solutions provider Vetter will enable track-and-trace packaging in order to mitigate drug counterfeiting. Expected to be offered by the end of the year, the packaging serialisation will allow pharmaceutical and biotech firms to clearly identify pharmaceuticals on packaging.

According to Vetter, several nations have considered serialisation as a solution to prevent counterfeiting problems, with the US, South Korea, Brazil and several European nations set to implement it. Vetter managing director Thomas Otto said that the serialisation service would support the customer and regulatory demands in the development of track-and-trace programmes to end drug counterfeiting.

"This service, which we expect to have implemented by late 2014, is based upon a comprehensive concept study that we undertook," Otto added. "Our serialisation service will enable that packages include unique identification necessary to support product security and supply chain efficiency."

Vetter operates as a contract development and manufacturing organisation that specialises in the aseptic filling of syringes, cartridges and vials. The serialisation service will expand its existing services, that include the printing of global trade item numbers (GTIN) on packages for customers in France and the US.

Related News

no news in this list.